Cargando…

Regulatory utility of mechanistic modeling to support alternative bioequivalence approaches: A workshop overview

On September 30 and October 1, 2021, the US Food and Drug Administration (FDA) and the Center for Research on Complex Generics cosponsored a live virtual workshop titled “Regulatory Utility of Mechanistic Modeling to Support Alternative Bioequivalence Approaches.” The overall aims of the workshop in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Babiskin, Andrew, Wu, Fang, Mousa, Youssef, Tan, Ming‐Liang, Tsakalozou, Eleftheria, Walenga, Ross L., Yoon, Miyoung, Raney, Sam G., Polli, James E., Schwendeman, Anna, Krishnan, Vishalakshi, Fang, Lanyan, Zhao, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196436/ https://www.ncbi.nlm.nih.gov/pubmed/36631942 http://dx.doi.org/10.1002/psp4.12920

Ejemplares similares

Increasing impact of quantitative methods and modeling in establishment of bioequivalence and characterization of drug delivery
por: Yoon, Miyoung, et al.
Publicado: (2023)

Physiologically‐based pharmacokinetic modeling to support bioequivalence and approval of generic products: A case for diclofenac sodium topical gel, 1%
por: Tsakalozou, Eleftheria, et al.
Publicado: (2021)

Mechanistic modeling of drug products applied to the skin: A workshop summary report
por: Tsakalozou, Eleftheria, et al.
Publicado: (2022)

Research and Education Needs for Complex Generics
por: Stern, Sydney, et al.
Publicado: (2021)

Establishing the suitability of model‐integrated evidence to demonstrate bioequivalence for long‐acting injectable and implantable drug products: Summary of workshop
por: Gong, Yuqing, et al.
Publicado: (2023)

Mechanistic modeling of ophthalmic, nasal, injectable, and implant generic drug products: A workshop summary report
por: Tan, Ming‐Liang, et al.
Publicado: (2023)

Mechanistic Oral Absorption Modeling and Simulation for Formulation Development and Bioequivalence Evaluation: Report of an FDA Public Workshop
por: Zhang, X, et al.
Publicado: (2017)

Regulatory utility of physiologically‐based pharmacokinetic modeling to support alternative bioequivalence approaches and risk assessment: A workshop summary report
por: Wu, Fang, et al.
Publicado: (2023)

In Silico Methods for Development of Generic Drug–Device Combination Orally Inhaled Drug Products
por: Walenga, Ross L., et al.
Publicado: (2019)

Development of a Pediatric Relative Bioavailability/Bioequivalence Database and Identification of Putative Risk Factors Associated With Evaluation of Pediatric Oral Products
por: Pawar, Gopal, et al.
Publicado: (2021)

Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report
por: Al Shoyaib, Abdullah, et al.
Publicado: (2023)

Update on the safety and bioequivalence of biosimilars – focus on enoxaparin
por: Jeske, Walter, et al.
Publicado: (2013)

Quantitative methods and modeling to assess COVID‐19‐interrupted in vivo pharmacokinetic bioequivalence studies with two reference batches
por: Gong, Yuqing, et al.
Publicado: (2022)

Evaluation of model‐based bioequivalence approach for single sample pharmacokinetic studies
por: Tardivon, Coralie, et al.
Publicado: (2023)

Clinical Ocular Exposure Extrapolation for Ophthalmic Solutions Using PBPK Modeling and Simulation
por: Le Merdy, Maxime, et al.
Publicado: (2022)

Mechanistic modeling of generic orally inhaled drug products: A workshop summary report
por: Walenga, Ross L., et al.
Publicado: (2022)

Multi‐phase multi‐layer mechanistic dermal absorption (MPML MechDermA) model to predict local and systemic exposure of drug products applied on skin
por: Patel, Nikunjkumar, et al.
Publicado: (2022)

A quasi-3D model of the whole lung: airway extension to the tracheobronchial limit using the constrained constructive optimization and alveolar modeling, using a sac–trumpet model
por: Kannan, Ravishekar (Ravi), et al.
Publicado: (2021)

Open Flow Microperfusion as a Dermal Pharmacokinetic Approach to Evaluate Topical Bioequivalence
por: Bodenlenz, Manfred, et al.
Publicado: (2016)

Evaluation of pharmacokinetics and safety with bioequivalence of Amlodipine in healthy Chinese volunteers: Bioequivalence Study Findings
por: Wang, Tongtong, et al.
Publicado: (2020)

Overview of the European Medicines Agency's Development of Product‐Specific Bioequivalence Guidelines
por: Sullivan, Jane O', et al.
Publicado: (2018)

A General Framework for Assessing In vitro/In vivo Correlation as a Tool for Maximizing the Benefit‐Risk Ratio of a Treatment Using a Convolution‐Based Modeling Approach
por: Gomeni, Roberto, et al.
Publicado: (2019)

Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer Cells
por: Tsakalozou, Eleftheria, et al.
Publicado: (2012)

Variability of Skin Pharmacokinetic Data: Insights from a Topical Bioequivalence Study Using Dermal Open Flow Microperfusion
por: Bodenlenz, Manfred, et al.
Publicado: (2020)

Transport and deposition of hygroscopic particles in asthmatic subjects with and without airway narrowing
por: Rajaraman, Prathish K., et al.
Publicado: (2020)

Bioequivalence: tried and tested
por: Schall, Robert, et al.
Publicado: (2010)

Bioequivalence studies in Morocco
por: Zaoui, Sanaa, et al.
Publicado: (2020)

Bioequivalence data analysis
por: Park, Gowooni, et al.
Publicado: (2020)

A mechanistic pharmacokinetic model with drug and antidrug antibody interplay, and its application for assessing the impact of immunogenicity response on bioequivalence testing
por: Liao, Kai H., et al.
Publicado: (2020)

Welcome & Overview of the workshop
por: LE MEUR, Jean-Yves
Publicado: (2015)

Introduction and overview of the workshop
por: Kraml, Sabine
Publicado: (2021)

Bioequivalence assessment of two formulations of ibuprofen
por: Al-Talla, Zeyad A, et al.
Publicado: (2011)

Pharmacokinetics and Bioequivalence Evaluation of Cyclobenzaprine Tablets
por: Brioschi, Tatiane Maria de Lima Souza, et al.
Publicado: (2013)

Focus on biosimilar etanercept – bioequivalence and interchangeability
por: Cantini, Fabrizio, et al.
Publicado: (2018)

The Case for Standardizing the Appearance of Bioequivalent Medications
por: Engelberg, Alfred B.
Publicado: (2011)

Stress Signaling in Cyanobacteria: A Mechanistic Overview
por: Rachedi, Raphaël, et al.
Publicado: (2020)

Between-Batch Bioequivalence (BBE): a Statistical Test to Evaluate In Vitro Bioequivalence Considering the Between-Batch Variability
por: Bodin, Jonathan, et al.
Publicado: (2020)

Current Bioequivalence Study Designs in South Korea: A Comprehensive Analysis of Bioequivalence Study Reports Between 2013 and 2019
por: Huh, Ki Young, et al.
Publicado: (2021)

Evaluation of Pharmacokinetics and Safety with Bioequivalence of Ibuprofen Sustained-Release Capsules of Two Formulations, in Chinese Healthy Volunteers: Bioequivalence Study
por: Huang, Chunqi, et al.
Publicado: (2023)

Quantification of anandamide, oleoylethanolamide and palmitoylethanolamide in rodent brain tissue using high performance liquid chromatography–electrospray mass spectroscopy
por: Liput, Daniel J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vomkbuti2nf8qcceve74ul0360